Plus Therapeutics (PSTV) Amortization of Deferred Charges (2010 - 2024)
Plus Therapeutics (PSTV) reported Amortization of Deferred Charges of $4000.0 for Q2 2024, down 92.45% year-over-year from $53000.0 in Q3 2023, and down 75.0% quarter-over-quarter from $16000.0 in Q1 2024.
Plus Therapeutics (PSTV) Amortization of Deferred Charges (2010 - 2024) Analysis & Trends
Plus Therapeutics (PSTV) has 15 years of Amortization of Deferred Charges data on file, last reported at $4000.0 in Q2 2024.
- Amortization of Deferred Charges for Q2 2024 came in at $4000.0, down 92.45% year-over-year; the trailing twelve-month figure through Dec 2024 was $20000.0 (down 89.47% YoY), and the FY2024 annual result was $20000.0, down 89.47% from the prior year.
- Amortization of Deferred Charges slipped to $4000.0 in Q2 2024 per PSTV's latest filing, from $16000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $156000.0 in Q4 2020 and troughed at $4000.0 in Q2 2024.
- A 5-year average of $96055.6 and a median of $109000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2020 and 2024: Amortization of Deferred Charges jumped 71.91% in 2020, then sank 92.45% in 2024.
- A 5-year view of Amortization of Deferred Charges shows it stood at $156000.0 in 2020, then declined by 17.31% to $129000.0 in 2021, then tumbled by 37.98% to $80000.0 in 2022, then sank by 62.5% to $30000.0 in 2023, then sank by 86.67% to $4000.0 in 2024.
- Business Quant data shows PSTV's Amortization of Deferred Charges at $4000.0 in Q2 2024, $16000.0 in Q1 2024, and $30000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Plus Therapeutics | 34.26 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Jun 30, 2023 | 53,000.00 |
| Jun 30, 2023 | 53,000.00 |
| Mar 31, 2023 | 66,000.00 |
| Mar 31, 2023 | 66,000.00 |
| Dec 31, 2022 | 80,000.00 |
| Dec 31, 2022 | 80,000.00 |
| Sep 30, 2022 | 91,000.00 |
| Sep 30, 2022 | 91,000.00 |
| Jun 30, 2022 | 103,000.00 |
| Jun 30, 2022 | 103,000.00 |
| Mar 31, 2022 | 115,000.00 |
| Mar 31, 2022 | 115,000.00 |